Figure 1.
Figure 1. RAB1B expression in platelets from the patients with RUNX1 haplodeficiency and healthy control subjects. (A) Platelets RAB1B mRNA levels in the index (P1) patient and 5 normal subjects (N1-N5) by quantitative PCR. Shown are mRNA levels normalized to GAPDH. (B) Immunofluorescence studies of platelet RAB1B expression in the index patient P1 and a normal subject. Platelets were labeled with RAB1B polyclonal antibody, detected with fluorescein isothiocyanate (pseudocolored red)–conjugated secondary antibody, and imaged on a Nikon E1000 microscope. Corrected total cell immunofluorescence is shown ± SEM. (C) Platelet RAB1B mRNA in 2 siblings (P2 and P3) from a second family with RUNX1 mutation and 5 normal subjects (N1-N5). (D) Platelet RAB1B immunofluorescence in patient P2 and 2 normal subjects. Bar, 10 μm (scale also applies to panel B). Corrected total cellular fluorescence is shown ± SEM. The P values represent comparisons of the patient with each of the control subjects. (E) Platelet RAB1B by immunoblotting in 3 patients (P1-P3) and 5 healthy subjects (N1-N5). Also shown is the ratio of RAB1B to GAPDH.

RAB1B expression in platelets from the patients with RUNX1 haplodeficiency and healthy control subjects. (A) Platelets RAB1B mRNA levels in the index (P1) patient and 5 normal subjects (N1-N5) by quantitative PCR. Shown are mRNA levels normalized to GAPDH. (B) Immunofluorescence studies of platelet RAB1B expression in the index patient P1 and a normal subject. Platelets were labeled with RAB1B polyclonal antibody, detected with fluorescein isothiocyanate (pseudocolored red)–conjugated secondary antibody, and imaged on a Nikon E1000 microscope. Corrected total cell immunofluorescence is shown ± SEM. (C) Platelet RAB1B mRNA in 2 siblings (P2 and P3) from a second family with RUNX1 mutation and 5 normal subjects (N1-N5). (D) Platelet RAB1B immunofluorescence in patient P2 and 2 normal subjects. Bar, 10 μm (scale also applies to panel B). Corrected total cellular fluorescence is shown ± SEM. The P values represent comparisons of the patient with each of the control subjects. (E) Platelet RAB1B by immunoblotting in 3 patients (P1-P3) and 5 healthy subjects (N1-N5). Also shown is the ratio of RAB1B to GAPDH.

Close Modal

or Create an Account

Close Modal
Close Modal